Huanjie Li
- Molecular Biology
- Physiology
- Epidemiology
- Biochemistry top 5%
- Infectious Diseases top 10%
- Topics
- SARS-CoV-2 and COVID-19 Research (6 papers)Sulfur Compounds in Biology (5 papers)COVID-19 Clinical Research Studies (3 papers)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Huanjie Li
37 papers receiving 950 citations
Peers
Comparison fields: 5 of 117
- Molecular Biology 434
- Physiology 165
- Epidemiology 132
- Biochemistry 120
- Infectious Diseases 116
Countries citing papers authored by Huanjie Li
This map shows the geographic impact of Huanjie Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huanjie Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huanjie Li more than expected).
Fields of papers citing papers by Huanjie Li
This network shows the impact of papers produced by Huanjie Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huanjie Li. The network helps show where Huanjie Li may publish in the future.
Co-authorship network of co-authors of Huanjie Li
This figure shows the co-authorship network connecting the top 25 collaborators of Huanjie Li. A scholar is included among the top collaborators of Huanjie Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huanjie Li. Huanjie Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 5 | |
| 7 | 64 | |
| 8 | 55 | |
| 9 | 12 | |
| 10 | 26 | |
| 11 | 38 | |
| 12 | 30 | |
| 13 | 45 | |
| 14 | 89 | |
| 15 | 19 | |
| 16 | 6 | |
| 17 | 22 | |
| 18 | 17 | |
| 19 | 28 | |
| 20 | 1 |
About Huanjie Li
Huanjie Li is a scholar working on Biochemistry, Infectious Diseases and Health, having authored 38 papers that have together received 959 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), Sulfur Compounds in Biology (5 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Biochemistry (120 citations), Process Chemistry and Technology (23 citations) and Physiology (165 citations). Huanjie Li has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Dongqi Tang, Lei Shao, Wenjuan Wang, Yunshan Wang, Luying Xun, Huaiwei Liu, Yongzhen Xia, Xing Li Wang, Taixing Cui and Joseph S. Janicki. Their work appears in journals such as PLoS ONE, Analytical Chemistry and Applied and Environmental Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.